COMMUNIQUÉS West-GlobeNewswire

-
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
27/06/2024 - 22:01 -
Elicio Therapeutics Announces Preliminary Disease-Free Survival analysis from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P
27/06/2024 - 22:01 -
Journal of Respirology Publishes Clinical Trial Data Demonstrating the Benefits of Noah Medical’s Galaxy System
27/06/2024 - 20:39 -
Healthcare Financial Management Association Recognizes Center for Medicare and Medicaid Innovation Director Elizabeth Fowler for Contributions to Healthcare
27/06/2024 - 20:30 -
Ezra Launches AI-Fueled, Whole-Body MRI in Seattle in Partnership with Imaging Leader RAYUS Radiology
27/06/2024 - 19:55 -
Bioxytran’s Advisor Releases Book on Hyperbaric Oxygenation Related to Stroke & Alzheimer’s Patients
27/06/2024 - 19:09 -
La revue Allergy désignée comme publication ayant le plus grand impact en allergologie et immunologie clinique pour 2024
27/06/2024 - 18:10 -
PHAXIAM Therapeutics annonce le succès de son augmentation de capital avec maintien du droit préférentiel de souscription de 7,8 M€
27/06/2024 - 17:45 -
Nicox: 2024 Ordinary Shareholder Meeting
27/06/2024 - 17:30 -
Nicox : Assemblée Générale Ordinaire 2024
27/06/2024 - 17:30 -
CloudMD Securityholders Approve Go-Private Transaction with CPS Capital
27/06/2024 - 17:11 -
Dermatology Group of Arkansas Member Earns Nursing Degree
27/06/2024 - 16:57 -
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union
27/06/2024 - 16:30 -
LSL Pharma Group Secures $1.5 Million as the First Closing of Its Non-Brokered Private Placement
27/06/2024 - 16:27 -
Nexstim Plc Has Agreed on a Digitalization and Innovation Loan with Finnvera to Finance Product Development Project
27/06/2024 - 15:45 -
Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials
27/06/2024 - 15:41 -
GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemia
27/06/2024 - 15:15 -
KFSH&RC Leads Global Healthcare Revolution with AI and Robotics
27/06/2024 - 15:00 -
bioLytical Donates 1200 HIV Testing Kits Across the United States to Support National HIV Testing Day
27/06/2024 - 15:00
Pages